AU2019900991A0 - Treating immune platelet disorders using antigen-binding fragments - Google Patents

Treating immune platelet disorders using antigen-binding fragments

Info

Publication number
AU2019900991A0
AU2019900991A0 AU2019900991A AU2019900991A AU2019900991A0 AU 2019900991 A0 AU2019900991 A0 AU 2019900991A0 AU 2019900991 A AU2019900991 A AU 2019900991A AU 2019900991 A AU2019900991 A AU 2019900991A AU 2019900991 A0 AU2019900991 A0 AU 2019900991A0
Authority
AU
Australia
Prior art keywords
antigen
binding fragments
treating immune
platelet disorders
immune platelet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019900991A
Inventor
Beng Hock Chong
Halina Hoi Laam Leung
Jose Sail Perdomo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nsw Health Pathology
South Eastern Sydney Area Health Service
NewSouth Innovations Pty Ltd
Original Assignee
Nsw Health Pathology
South Eastern Sydney Area Health Service
NewSouth Innovations Pty Ltd
Filing date
Publication date
Application filed by Nsw Health Pathology, South Eastern Sydney Area Health Service, NewSouth Innovations Pty Ltd filed Critical Nsw Health Pathology
Publication of AU2019900991A0 publication Critical patent/AU2019900991A0/en
Assigned to NEWSOUTH INNOVATIONS PTY LIMITED, SOUTH EASTERN SYDNEY AREA HEALTH SERVICE, NSW Health Pathology reassignment NEWSOUTH INNOVATIONS PTY LIMITED Amend patent request/document other than specification (104) Assignors: NSW Health Pathology, SOUTH EASTERN SYDNEY AREA HEALTH SERVICE, UNIVERSITY OF NEW SOUTH WALES
Priority to PCT/AU2020/050284 priority Critical patent/WO2020191441A1/en
Priority to CN202080038668.9A priority patent/CN114430683A/en
Priority to US17/442,791 priority patent/US20230052153A1/en
Priority to AU2020249187A priority patent/AU2020249187A1/en
Abandoned legal-status Critical Current

Links

AU2019900991A 2019-03-25 2019-03-25 Treating immune platelet disorders using antigen-binding fragments Abandoned AU2019900991A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PCT/AU2020/050284 WO2020191441A1 (en) 2019-03-25 2020-03-25 Treating immune platelet disorders using antigen-binding fragments
CN202080038668.9A CN114430683A (en) 2019-03-25 2020-03-25 Treatment of immune platelet disorders using antigen binding fragments
US17/442,791 US20230052153A1 (en) 2019-03-25 2020-03-25 Treating immune platelet disorders using antigen-binding fragments
AU2020249187A AU2020249187A1 (en) 2019-03-25 2020-03-25 Treating immune platelet disorders using antigen-binding fragments

Publications (1)

Publication Number Publication Date
AU2019900991A0 true AU2019900991A0 (en) 2019-04-11

Family

ID=

Similar Documents

Publication Publication Date Title
EP3746135A4 (en) Methods and compounds for treating disorders
EP3570844A4 (en) Azolopyrimidine for the treatment of cancer-related disorders
WO2015197823A3 (en) Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
EP3880239A4 (en) THERAPEUTIC SIRPalpha ANTIBODIES
EP3713955A4 (en) Anti-ifnar1 antibodies for treating autoimmune diseases
EP3253412A4 (en) Anti-cd40l antibodies and methods for treating cd40l-related diseases or disorders
EP3844156A4 (en) Treating liver disorders
EP3856169A4 (en) Methods of treating myeloproliferative disorders
EP3826650A4 (en) Methods of treating neurological disorders
EP3606542A4 (en) Proteins for the treatment of epithelial barrier function disorders
EP3566055A4 (en) Methods for the treatment of neurological disorders
EP3773491A4 (en) Methods for treating apoe4/4-associated disorders
EP3826649A4 (en) Methods of treating neurological disorders
EP4003994A4 (en) Treatment of immune evasive tumors
EP4025211A4 (en) Methods of treating epilepsy using the same
EP3856207A4 (en) Treatment methods
EP3856198A4 (en) Low-intensity treatment of hematological disorders
EP3840752A4 (en) Platelet count-agnostic methods of treating myelofibrosis
EP3773644A4 (en) Proteins for the treatment of epithelial barrier function disorders
EP3953559A4 (en) Multi-component downhole treatment
EP3559892A4 (en) Methods for treating mitochondrial disorders
EP3880250A4 (en) Methods for treating immune related ocular disorders
EP3856241A4 (en) Treatment methods
EP3829548A4 (en) Immune modifying particles for the treatment of cancer
EP3735129A4 (en) Compositions and methods for treating neurological and other disorders